213 related articles for article (PubMed ID: 8423407)
1. Control of fibrosis in systemic scleroderma.
Mauch C; Eckes B; Hunzelmann N; Oono T; Kozlowska E; Krieg T
J Invest Dermatol; 1993 Jan; 100(1):92S-96S. PubMed ID: 8423407
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of scleroderma. Collagen.
Jimenez SA; Hitraya E; Varga J
Rheum Dis Clin North Am; 1996 Nov; 22(4):647-74. PubMed ID: 8923589
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue metabolism including cytokines.
Amento EP
Curr Opin Rheumatol; 1989 Dec; 1(4):485-9. PubMed ID: 2702050
[No Abstract] [Full Text] [Related]
4. Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis.
Mauch C; Kreig T
Rheum Dis Clin North Am; 1990 Feb; 16(1):93-107. PubMed ID: 2406813
[TBL] [Abstract][Full Text] [Related]
5. Cytokines and human fibrosis.
LeRoy EC; Trojanowska MI; Smith EA
Eur Cytokine Netw; 1990; 1(4):215-9. PubMed ID: 1966552
[TBL] [Abstract][Full Text] [Related]
6. Connective tissue metabolism including cytokines in scleroderma.
Smith EA
Curr Opin Rheumatol; 1992 Dec; 4(6):869-77. PubMed ID: 1457283
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
8. Activation of dermal connective tissue in scleroderma.
Kähäri VM
Ann Med; 1993 Dec; 25(6):511-8. PubMed ID: 8292298
[TBL] [Abstract][Full Text] [Related]
9. Scleroderma, fibroblasts, signaling, and excessive extracellular matrix.
Ihn H
Curr Rheumatol Rep; 2005 Apr; 7(2):156-62. PubMed ID: 15760596
[TBL] [Abstract][Full Text] [Related]
10. Increased adhesion of fibroblasts from patients with scleroderma to extracellular matrix components: in vitro modulation by IFN-gamma but not by TGF-beta.
Majewski S; Hunzelmann N; Schirren CG; Mauch C; Aumailley M; Krieg T
J Invest Dermatol; 1992 Jan; 98(1):86-91. PubMed ID: 1728642
[TBL] [Abstract][Full Text] [Related]
11. Altered regulation of collagen metabolism in scleroderma fibroblasts grown within three-dimensional collagen gels.
Mauch C; Kozlowska E; Eckes B; Krieg T
Exp Dermatol; 1992 Nov; 1(4):185-90. PubMed ID: 1365320
[TBL] [Abstract][Full Text] [Related]
12. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
13. What did we learn by studying scleroderma fibroblasts?
Trojanowska M
Clin Exp Rheumatol; 2004; 22(3 Suppl 33):S59-63. PubMed ID: 15344599
[TBL] [Abstract][Full Text] [Related]
14. Regulation of connective tissue synthesis in systemic sclerosis.
Varga J; Bashey RI
Int Rev Immunol; 1995; 12(2-4):187-99. PubMed ID: 7650421
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in fibroblast signaling and biology in scleroderma.
Pannu J; Trojanowska M
Curr Opin Rheumatol; 2004 Nov; 16(6):739-45. PubMed ID: 15577613
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology of fibroses. Progressive systemic scleroderma as a model disease].
Hein R; Mauch C; Braun-Falco O; Krieg T
Hautarzt; 1988 Feb; 39(2):65-71. PubMed ID: 3283077
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1.
Shi-Wen X; Denton CP; Dashwood MR; Holmes AM; Bou-Gharios G; Pearson JD; Black CM; Abraham DJ
J Invest Dermatol; 2001 Mar; 116(3):417-25. PubMed ID: 11231316
[TBL] [Abstract][Full Text] [Related]
18. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
20. [Transforming growth factor-beta and its receptors in scleroderma].
QIAN H; ZHENG M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):415-21. PubMed ID: 19693982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
